A level IV lymph node belongs to a group of nodes in the lower lateral neck, running along the bottom stretch of the internal jugular vein above the collarbone. In cancer staging, these nodes matter because they sit at a crossroads where cancers of the throat, larynx, and thyroid gland frequently spread, and their involvement often changes how aggressively a tumor needs to be treated. Confusingly, there is also a “station 4” in lung cancer staging that sits in the chest rather than the neck, and it carries its own clinical weight.
Where Level IV Sits in the Neck
The cervical lymph node classification system divides the neck into levels I through VI (with some sub-levels), each defined by anatomical landmarks that surgeons and radiation oncologists use to plan treatment. Level IV occupies the lower third of the internal jugular chain. Its upper boundary is roughly the inferior border of the cricoid cartilage (the ring of cartilage you can feel at the base of your throat), and it extends downward to the collarbone. On either side, it is bordered by the sternocleidomastoid muscle (the thick muscle running from behind your ear to your collarbone) and the lateral edge of the sternohyoid muscle closer to the midline.
This relatively small strip of tissue sits on top of critical anatomy. The thoracic duct, which drains lymph fluid from most of the body, empties into the venous system in this neighborhood, predominantly on the left side. The phrenic nerve, which controls the diaphragm, runs through the area. And the brachial plexus, the nerve network that supplies the arm, lies just behind it. These neighboring structures are one reason level IV surgery carries distinctive risks compared with dissection at higher neck levels.
A set of consensus guidelines from multiple international cooperative groups defined these boundaries for use in radiation therapy planning, standardizing how clinicians across different countries identify and target each node level.1PubMed. Delineation of the neck node levels for head and neck tumors: a 2013 update That standardization is important: if two oncologists in different hospitals are discussing “level IV,” they are talking about the same anatomical territory.
The Other “Level 4” in Lung Cancer
If your doctor mentions a level 4 lymph node in the context of lung cancer, they are almost certainly talking about a different map entirely. Lung cancer uses a mediastinal lymph node classification where stations are numbered 1 through 14. Station 4 refers to the lower paratracheal nodes, which sit alongside the lower trachea inside the chest. Station 4 is further divided into 4R (right side) and 4L (left side), and the distinction matters because the anatomy on each side is different and so is the difficulty of reaching those nodes during surgery or biopsy.
Station 4L, on the left side, has drawn particular attention. A study of patients with left-sided non-small cell lung cancer found that about 15% had metastases at station 4L. Patients who had those nodes formally dissected showed better five-year overall survival compared with those who did not: roughly 66% versus 56%.2PubMed. Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer The takeaway for surgeons is that skipping 4L dissection during left-sided lung cancer operations may leave behind disease that affects long-term outcomes.
Reaching station 4L is not straightforward. The left recurrent laryngeal nerve loops around the aortic arch and runs through the same zone where these nodes are dissected. An anatomical study found that using the phrenic and vagus nerves as landmarks during dissection puts the recurrent laryngeal nerve at risk in close to 60% of patients, because the nerve’s exact course varies from person to person.3PubMed Central. Nerve at risk: anatomical variations of the left recurrent laryngeal nerve and implications for thoracic surgeons Injury to this nerve causes vocal cord paralysis, which can impair coughing, swallowing, and voice quality. For thoracic surgeons, the clinical benefit of complete node dissection has to be weighed against this nerve injury risk on a patient-by-patient basis.
These mediastinal nodes can be sampled without open surgery. Endobronchial ultrasound with needle aspiration lets pulmonologists reach several mediastinal stations through the airway wall, though station 4R is more accessible than 4L due to the way the airways are arranged.4PubMed Central. Current Concepts in the Mediastinal Lymph Node Staging of Nonsmall Cell Lung Cancer Endoscopic ultrasound through the esophagus is another option, which works well for left-sided and lower mediastinal stations but has blind spots higher up.
Level IV and Head and Neck Cancer
Back in the neck, level IV nodes receive lymph drainage from the lower pharynx, larynx, thyroid, and cervical esophagus. When cancers in these areas spread to lymph nodes, level IV is often involved, though how commonly depends heavily on where the primary tumor sits.
Oropharyngeal cancers, particularly those arising at the base of the tongue, have a notable tendency to involve level IV. In a study of patients with oropharyngeal squamous cell carcinoma who underwent therapeutic neck dissection and had confirmed nodal metastases, level IV was involved in 37% of cases on the side of the tumor. Base-of-tongue tumors were strikingly worse: 86% of patients with nodal disease from base-of-tongue cancer had level IV involvement, compared with 34% for tonsillar cancer.5PubMed. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck Three patients in that study had isolated metastases at level IV with no disease at higher levels, a phenomenon called skip metastasis.
Skip metastasis is clinically important because it can catch surgeons off guard. If cancer bypasses levels I through III and appears only at level IV, a neck dissection that stops short of the lower neck would miss it. A meta-analysis looking at oral cavity squamous cell carcinoma in patients without clinically apparent node disease found that level IV was involved in about 2.5% of cases, and the rate of true skip metastasis (level IV involved without disease at higher levels) was around 0.5%.6JAMA Otolaryngology–Head & Neck Surgery. Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma That is a low absolute rate, but for the individual patient in whom it happens, the consequences of missing it are serious. The meta-analysis found that tumor stage and primary site did not significantly predict which patients would have skip metastases, making it difficult to identify them in advance.
For laryngeal cancer specifically, level IV involvement appears less common overall but tends to cluster in advanced tumors. A study of 77 patients with laryngeal carcinoma found that about 4% had metastatic nodes at level IV, and all three of those cases had T4 tumors, the most advanced local stage.7PubMed Central. Cervical metastasis on level IV in laryngeal cancer The pattern makes anatomical sense: larger tumors have more lymphatic channels to exploit and are more likely to reach the lower neck.
Level IV in Thyroid Cancer
Papillary thyroid carcinoma, the most common form of thyroid cancer, has a strong predilection for level IV when it spreads to the lateral neck. The thyroid gland sits right in front of the trachea, and its lymphatic drainage flows laterally into levels III, IV, and the lower part of level II. One study of papillary thyroid carcinoma patients with lateral neck metastases found that level IV was involved in about 76% of cases, making it the single most commonly affected lateral compartment level.8PubMed. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection A second study put the figure somewhat lower, at roughly 62%, but still confirmed level IV as one of the top two most frequently involved levels alongside level III.9PubMed. Metastatic papillary thyroid cancer with lateral neck disease: pattern of spread by level
These numbers have a direct bearing on surgical planning. When a thyroid cancer patient has confirmed lateral neck metastases, most surgeons will include levels II through V in the dissection rather than selectively clearing only the levels that look abnormal on imaging. The high rate of level IV involvement, even when other levels appear clean on a scan, supports this comprehensive approach.
How Level IV Nodes Are Detected
Enlarged or abnormal-looking lymph nodes at level IV are usually first spotted on imaging. Ultrasound is the go-to tool for evaluating neck nodes because it can distinguish features like abnormal shape, loss of the normal fatty center, and increased blood flow. CT and MRI provide a broader view, especially for nodes that are deep or hard to reach with an ultrasound probe.
PET/CT scans, which detect metabolically active tissue, add another layer of information. A study of oncology patients found that PET/CT alone achieved about 81% sensitivity and 69% specificity for detecting metastatic cervical lymph nodes. Adding a follow-up ultrasound raised specificity to about 88% and overall accuracy to 83%, a meaningful improvement that reduced false positives.10PubMed Central. Cervical Lymph Nodes Detected by F-18 FDG PET/CT in Oncology Patients: Added Value of Subsequent Ultrasonography for Determining Nodal Metastasis In practice, clinicians often use a combination: a PET/CT to survey the whole body for suspicious activity, followed by a targeted ultrasound and needle biopsy to confirm whether a specific node is truly cancerous.
Fine-needle aspiration, where a thin needle is guided into a suspicious node under ultrasound, remains the standard way to confirm metastatic disease before committing to surgery. For mediastinal station 4 nodes in lung cancer, the approach is different: those nodes live inside the chest, so sampling typically requires bronchoscopy-based ultrasound or endoscopic ultrasound, as described earlier.
Surgical Risks Specific to Level IV Dissection
Operating at level IV in the neck carries hazards that are less common at higher levels. The thoracic duct and its right-sided equivalent are vulnerable to injury during dissection in this area. A chyle leak, where lymphatic fluid seeps into the surgical field or accumulates under the skin, occurs in roughly 5.5 to 6% of level IV dissections.11PubMed Central. The neck matters: optimising lymph node management in laryngeal cancer Chyle leaks are overwhelmingly more common on the left side, where the thoracic duct is larger and more prominent. One series found that 9 out of 12 chyle leaks following neck dissection occurred on the left, and only 2 of the 12 followed isolated right-sided dissections.12PubMed. Predictors for Postoperative Chyle Leak Following Neck Dissection, a Technique-Based Comparison Most chyle leaks can be managed conservatively with dietary changes and drainage, but severe cases occasionally need repeat surgery.
The phrenic nerve is another concern. It passes through or near level IV on its way to the diaphragm. Injury can cause paralysis of one side of the diaphragm, which may produce breathlessness that ranges from barely noticeable to functionally limiting depending on the patient’s baseline lung function. Reported rates of phrenic nerve injury during neck dissection that includes level IV range from about 3% to 8%.11PubMed Central. The neck matters: optimising lymph node management in laryngeal cancer
Shoulder dysfunction is more associated with level II and the spinal accessory nerve, but level IV dissection can contribute. Even with nerve-sparing techniques at level II, full shoulder recovery is reported in only about 70 to 75% of patients.11PubMed Central. The neck matters: optimising lymph node management in laryngeal cancer The cumulative trauma of dissecting across multiple levels compounds the problem.
What Level IV Involvement Means for Prognosis
When cancer reaches level IV nodes, it generally signals a worse prognosis compared with disease confined to higher neck levels. In oropharyngeal cancer, patients with level IV metastasis had a five-year disease-free survival of 54%, compared with 71% for patients whose metastases were limited to other levels.5PubMed. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck The lower neck is farther from most primary tumor sites, so involvement there suggests the cancer has spread more extensively through the lymphatic system.
Another prognostic factor that comes up during nodal evaluation is extranodal extension, where cancer cells break through the outer wall of a lymph node and invade surrounding tissue. This finding, detected on the final pathology report after surgery, is now formally built into the staging system for HPV-negative head and neck squamous cell carcinoma. It is associated with higher rates of distant metastasis and lower rates of regional disease control, and its presence typically triggers the addition of chemotherapy to postoperative radiation.13PubMed Central. Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer Extranodal extension can occur at any node level, but the broader point is that the pathological details of what is happening inside and around a metastatic node often matter as much as which level it sits in.
For lung cancer patients with mediastinal node involvement, the response to preoperative treatment is a strong predictor of long-term outcomes. Patients whose nodes are downstaged to show no remaining tumor after induction therapy have substantially better survival than those with persistent nodal disease. One study found five-year survival of about 36% in patients downstaged to node-negative status, versus only 9% in those with residual tumor in their nodes after treatment.14The Annals of Thoracic Surgery. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival The node station involved matters less than whether treatment clears the disease from the nodes entirely.
When an Enlarged Level IV Node Is Not Cancer
Not every enlarged node at level IV means malignancy. Reactive lymphadenopathy from infection is common in the neck, particularly in younger adults and children. Upper respiratory infections, dental infections, and mononucleosis can all cause neck nodes to swell, including at level IV. Certain systemic conditions like sarcoidosis and autoimmune diseases can also produce persistent lymph node enlargement.
Imaging features help distinguish benign from malignant nodes. Benign reactive nodes tend to be oval, have a preserved fatty hilum (the bright center visible on ultrasound), and show normal blood-flow patterns. Malignant nodes are more likely to be round, have lost their fatty center, and display irregular or peripheral blood flow. Still, overlap exists, and when imaging is ambiguous, a needle biopsy settles the question. The clinical context matters too: a single mildly enlarged level IV node in a 25-year-old with a recent cold means something very different from one in a 60-year-old smoker with a sore throat that has lasted three months.
Lymphoma deserves separate mention because it is one of the most common non-carcinoma cancers to present as enlarged neck nodes. Lymphoma nodes at level IV look different on imaging than squamous cell carcinoma metastases and frequently show up on both sides of the neck simultaneously. The distinction between a metastatic squamous cell node and a lymphoma node often requires tissue biopsy rather than imaging alone, but the treatment paths for these two diagnoses are entirely different: lymphoma is typically treated with chemotherapy and sometimes radiation, not surgery.